Discontinued — last reported Q3 '22
Advanced Micro Devices Acquisitions remained flat by 0.0% to $4.25M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 96.4%, from $117.00M to $4.25M.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $2.37B | $2.37B | -$3.17B | $0.00 | $0.00 | $0.00 | $14.00M | $117.00M | $4.25M | $4.25M | $4.25M | $4.25M |
| QoQ Change | — | — | — | — | +0.0% | -234.2% | +100.0% | — | — | — | +735.7% | -96.4% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | — | -100.0% | -100.0% | +100.4% | — | — | — | -69.6% | -96.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.